227 related articles for article (PubMed ID: 32914725)
1. An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis.
Singh S; Singh TG; Rehni AK
CNS Neurol Disord Drug Targets; 2020; 19(10):750-779. PubMed ID: 32914725
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.
Clossen BL; Reddy DS
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1519-1538. PubMed ID: 28179120
[TBL] [Abstract][Full Text] [Related]
3. Emerging perspectives on mitochondrial dysfunctioning and inflammation in epileptogenesis.
Singh S; Singh TG
Inflamm Res; 2021 Dec; 70(10-12):1027-1042. PubMed ID: 34652489
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.
Alyu F; Dikmen M
Acta Neuropsychiatr; 2017 Feb; 29(1):1-16. PubMed ID: 27692004
[TBL] [Abstract][Full Text] [Related]
5. Reviving mitochondrial bioenergetics: A relevant approach in epilepsy.
Singh S; Singh TG; Rehni AK; Sharma V; Singh M; Kaur R
Mitochondrion; 2021 May; 58():213-226. PubMed ID: 33775871
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E.
Ambrogini P; Torquato P; Bartolini D; Albertini MC; Lattanzi D; Di Palma M; Marinelli R; Betti M; Minelli A; Cuppini R; Galli F
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1098-1112. PubMed ID: 30703511
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy.
Henshall DC
Biochem Soc Trans; 2007 Apr; 35(Pt 2):421-3. PubMed ID: 17371290
[TBL] [Abstract][Full Text] [Related]
8. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies.
Li W; Wu J; Zeng Y; Zheng W
Front Immunol; 2023; 14():1269241. PubMed ID: 38187384
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
11. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ
J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963
[TBL] [Abstract][Full Text] [Related]
12. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?
Dingledine R; Varvel NH; Dudek FE
Adv Exp Med Biol; 2014; 813():109-22. PubMed ID: 25012371
[TBL] [Abstract][Full Text] [Related]
13. A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.
Amini E; Rezaei M; Mohamed Ibrahim N; Golpich M; Ghasemi R; Mohamed Z; Raymond AA; Dargahi L; Ahmadiani A
Mol Neurobiol; 2015 Aug; 52(1):492-513. PubMed ID: 25195699
[TBL] [Abstract][Full Text] [Related]
14. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
15. Microglia-Neuron Communication in Epilepsy.
Eyo UB; Murugan M; Wu LJ
Glia; 2017 Jan; 65(1):5-18. PubMed ID: 27189853
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.
Younus I; Reddy DS
Pharmacol Ther; 2017 Sep; 177():108-122. PubMed ID: 28279785
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in epileptogenesis after traumatic brain injury.
Webster KM; Sun M; Crack P; O'Brien TJ; Shultz SR; Semple BD
J Neuroinflammation; 2017 Jan; 14(1):10. PubMed ID: 28086980
[TBL] [Abstract][Full Text] [Related]
18. Calpain activation and neuronal death during early epileptogenesis.
Lam PM; González MI
Neurobiol Dis; 2019 Apr; 124():141-151. PubMed ID: 30423475
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
Louboutin JP; Strayer DS
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
Wong M
Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
